Top Net Payout Yield Stocks To Invest In 2015

Background of the Proposed Spin-Off

On November 14 Kimberly Clark announced the board of directors had authorized management to pursue a tax-free spin-off of the health care business, currently planned for 3Q, 2014. A spin-off would create a stand-alone, publicly traded health care company with approximately $1.6 billion in annual sales, 70% of which are derived from North America and net sales and leading market positions in both surgical and infection prevention products and medical devices (the maker of surgical masks, catheters, surgical gowns and drapes and other sterile supplies.) Robert Abernathy joined Kimberly-Clark in 1982 and is currently Kimberly-Clark Group President. He and 16,000 other employees would lead K-C Healthcare globally.

Chairman and Chief Executive Officer Thomas J. Falk had this to say, "While K-C Health Care has been part of our company since the 1970's, its strategic fit and growth priorities have changed over time and we now think that pursuing a spin-off makes sense for our shareholders. This move would allow K-C Health Care to optimize its performance and flexibility to pursue its own value-creation opportunities. A spin-off would also allow us to further sharpen our focus on our consumer and K-C Professional brands. This announcement is further evidence of our focus on creating shareholder value and how we use portfolio management to run our company." �� think the two companies will be better run as separate organizations rather than together,��he added.

Top Japanese Stocks To Buy For 2016: SBM Offshore NV (SBMO)

SBM Offshore NV is the Netherlands-based company engaged in the offshore energy industry. It is a provider of floating production and mooring systems, in production operations and in terminals and services. The Company�� main activity is the design, supply, installation and operation of floating production, storage and offloading (FPSO) vessels. The Company�� business is divided into two segments: Lease and Operate, providing leasing and operation of oil and gas production facilities, and Turnkey, providing engineering, supply, overhaul and maintenance of Catenary Anchor Leg Mooring (CALM) buoys, swivels, mooring systems, fluid transfer systems and offloading systems. The Company has four main project execution centers located in the Netherlands, Monaco, the United States and Malaysia, and operates a number of subsidiaries. On September 4, 2013, the Company sold its cryogenic hose system technology to Trelleborg Industrial Solutions, the business area of Trelleborg AB. Advisors' Opinion:

• [By Tom Stoukas]

  PSA Peugeot Citroen and Anglo American Plc led carmakers and mining companies lower, respectively, on concern demand from China will weaken. St. James�� Place Plc tumbled the most in 4 1/2 years after Lloyds Banking Group Plc sold 77 million shares in the British wealth manager. SBM Offshore NV (SBMO) jumped to the highest price in 13 months after saying its first-quarter revenue increased 35 percent.

Top Net Payout Yield Stocks To Invest In 2015: First Mexican Gold Corp (FMG)

First Mexican Gold Corp. (First Mexican) is exploration-stage company engaged principally in the acquisition, exploration and development of precious mineral properties through its wholly owned subsidiary, Cornelius Exploration S. de R.L. de C.V., in Mexico. The Hilda Properties consist of three properties: Hilda 30 property, the Hilda 37/38 property and Hilda 31/32 property. On January 1, 2011, the Company signed an agreement to acquire the Claim of Santa Martha, which consists of approximately 68 hectares in the district of Yecora, State of Sonora, Mexico. On February 4, 2011, the Company signed a letter of intent to acquire the claims of Vianney Fraccion III, San Martin and El Panda. On February 14, 2011, the Company signed a letter of intent to acquire the claims of El Hoyo and Santa Maria. On January 24, 2012, the Company completed its 80% option earn-in on the Guadalupe property in Sonora State, Mexico. On February 15, 2012, it acquired 100% interest of Guadalupe project. Advisors' Opinion:

• [By Adam Haigh]

  Fortescue Metals Group Ltd. (FMG) sank 4.2 percent after Teck Resources Ltd. sold a stake worth about A$500 million ($473 million) in Australia�� third-biggest iron-ore exporter. Sony Corp., a TV maker that gets 68 percent of sales outside Japan, lost 2.7 percent after the yen yesterday surged against the dollar, curbing the outlook for exporters. Samsung Electronics Co. preferred shares declined 5 percent in Seoul after Citigroup Inc. managed the sale of a $350 million stake in the electronics firm.

Top Net Payout Yield Stocks To Invest In 2015: Rite Aid Corp (RAD)

Rite Aid Corporation, incorporated in 1968, is a retail drugstore chain in the United States. As of March 3, 2012, the Company operated drugstores in 31 states across the country and in the District of Columbia. As of March 3, 2012, it operated 4,667 stores. In the Company�� stores, it sells prescription drugs and a range of other merchandise, which it calls front end products. During the fiscal year ended March 3, 2012 (fiscal 2012), prescription drug sales accounted for 68.1% of its total sales. The Company carries a range of front end products, which accounted for 31.9% of its total sales in fiscal 2012. Front end products include over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, beverages, convenience foods, greeting cards, seasonal merchandise and other everyday and convenience products, as well as photo processing. It offers a variety of products under its private brands, which contributed approximately 17% of its front end sales in the categories where private brand products were offered in fiscal 2012. As of March 3, 2012, the Company had opened over 2,100 GNC stores-within-Rite Aid-stores. During fiscal 2012, the Company sold two owned operating stores to independent third parties.

During fiscal 2012, its stores filled approximately 295 million prescriptions and served an average of 2.1 million customers per day. The overall average size of each store in its chain is approximately 12,600 square feet. As of March 3, 2012, 60% of its stores were freestanding; 51% of its stores included a drive-thru pharmacy; 24% included one-hour photo shops, and 46% included a GNC store-within-Rite Aid-store. The Company�� customers may also order prescription refills over the Internet through www.riteaid.com, or over the phone through its telephonic automated refill systems for pick up at a Rite Aid store. It has a strategic alliance with GNC, a retailer of vitamin and mineral supplements.

Advisors' Opinion:

• [By WALLSTCHEATSHEET]

  Rite Aid, through its stores across the United States, provides prescription drug and general merchandise products to consumers and companies. The stock has recently broken above a value range and is now trading at prices not seen for several years. Over the last four quarters, earnings have been improving while revenue figures have been declining, so, investors in the company have not been too pleased. Relative to its peers and sector, Rite Aid has led in year-to-date performance by a wide margin. Look for Rite Aid to continue to OUTPERFORM.

• [By Roberto Pedone]

  One potential earnings short-squeeze candidate is retail drugstore chain operator Rite Aid (RAD), which is set to release numbers on Thursday before the market open. Wall Street analysts, on average, expect Rite Aid to report revenue of $6.27 billion on a loss of 4 cents per share.

  The current short interest as a percentage of the float for Rite Aid is notable at 3.7%. That means that out of the 896 million shares in the tradable float, 33.54 million shares are sold short by the bears. The bears have also been increasing their bets from the last reporting period by 32%, or by about 8.13 million shares. If the bears get caught pressing their bets into a bullish quarter, then shares of RAD could easily explode higher post-earnings as the bears rush to cover some of their short bets.

  From a technical perspective, RAD is currently trending above its 50-day and 200-day moving averages, which is bullish. This stock has been uptrending strong for the last six months, with shares moving higher from its low of $1.65 to its recent high of $3.75 a share. During that uptrend, shares of RAD have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of RAD within range of triggering a major breakout trade post-earnings.

  If you're bullish on RAD, then I would wait until after its report and look for long-biased trades if this stock manages to break out above its 52-week high at $3.75 a share with high volume. Look for volume on that move that hits near or above its three-month average action of 20.36 million shares. If that breakout hits, then RAD will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $5 to $6 a share.

  I would avoid RAD or look for short-biased trades if after earnings it fails to trigger that breakout, and then drops back below some key near-term support levels at $3.53

• [By Daniel Jones]

  Throughout the past several years, the company has struck deals with Rite Aid (NYSE: RAD  ) , PetSmart, and Sam's Club, a segment of Wal-Mart. The company's most recent agreement involved it renewing its relationship with Rite Aid through 2019 and adding GNC locations to at least 300 additional Rite Aid stores. Using these relationships, GNC strives to increase its market share, but as I chronicled in�an earlier article, it has to accept some downsides. It is also provided some very attractive benefits.

• [By Jon C. Ogg]

  Rite Aid Corp. (NYSE: RAD) was reiterated at Outperform and the price target was raised to $6 from $5 after comparable sales were better than expected, according to Credit Suisse.

Top Net Payout Yield Stocks To Invest In 2015: Cosan Ltd (CZZ)

Cosan Limited (Cosan), incorporated on April 30, 2007, is a holding company. The Company is engaged in the production of ethanol and sugar, the marketing and distribution of fuel and lubricants in Brazil, and logistics services in the state of Sao Paulo, Brazil. The Company imports, exports, produces and sells ethanol, sugar, sugarcane and other sugar by-products. It distributes and sells fuel and other fuel by-products. The Company produces and markets electricity, steam and other co-generation by-products. During the fiscal year ended March 31, 2011 (fiscal 2011), it operated 24 mills. On February 18, 2011, Cosan, through its subsidiary Cosan S.A. Acucar e Alcool acquired 100% of the voting corporate capital of Cosan Araraquara Acucar e Alcool Ltda., (Usina Zanin).

The Company operates in three in segments: sugar and ethanol (S&E), fuel distribution and lubricants (CCL) and sugar logistics (Rumo Logistica). The sugar and ethanol segment operates and produces a range of sugar products, including raw, organic, crystal and refined sugars and consumer products under the Da Barra and Uniao brands, which are sold to a range of customers in Brazil and abroad, as well as produces and sells hydrous, anhydrous and industrial ethanol, which are sold to the Brazilian market. The sugar and ethanol segment also includes energy co-generation activities and land development businesses. Its fuel distribution and lubricants segment includes the distribution and marketing of fuels, mainly through franchised network of service stations under the brand Esso throughout the national territory, and production, distribution and marketing of lubricants licensed from ExxonMobil International Holdings B.V.. Its sugar logistics segment provides logistics services for the transport, storage and port lifting of sugar.

Sugar and Ethanol segment

As of March 31, 2011 the Company leased 437,698 hectares, through 2,128 land lease contracts with an average term of five years. During fiscal 2011,! it harvested from owned or leased lands 27.4 million tons, of the sugarcane and purchased from third-party growers the 26.8 million tons of sugarcane. During fiscal 2011, its accumulated sugar extraction was 139.0 kilograms of total sugar recovered (TSR) per ton of sugarcane and its agricultural yield was 91.4 tons of sugarcane per hectare. It produces ethanol through a chemical process called yeasting. It produces and sells three types of ethanol: hydrous ethanol and anhydrous ethanol for fuel and industrial ethanol. It sells ethanol through gasoline distributors in Brazil mainly at the mill that sell it to retailers that then sell it at the pump to customers.

During fiscal year 2011, the Company sold 4.3 million tons of sugar. The Company produces a range of standard sugars, including raw sugar, crystal sugar and organic sugar, and refined sugars, including granulated refined white sugar, amorphous refined sugar, refined sucrose liquid sugar and refined inverted liquid sugar. Its Sao Francisco mill and the Da Barra mill produce refined sugar. It also sells industrial alcohol, which is used in the chemical and pharmaceutical sectors. It sells sugar to a range of customers in Brazil and in the international markets. Its customers in Brazil include retail supermarkets, foodservice distributors and food manufacturers, for which it sells refined and liquid sugar.

Fuel distribution and lubricants

The Company�� fuel distribution business is engaged in sourcing, storing, blending and distributing primarily gasoline, ethanol, diesel and fuel oil through its retail network of approximately 4,500 Esso and Shell-branded stations. During fiscal 2011, it sold approximately 1.03 billion liters of fuels, consisting of 96.0% diesel and 4.0% gasoline, ethanol and other fuels to its industrial and wholesale clients. During fiscal 2011, Cosan Combustiveise Lubrificantes S.A. (CCL) sold a total of 166.4 million liters of lubricants. Its lubricant operations consist of a wholly o! wned Lubr! icants Oil Blending Plant (LOBP), located in Rio de Janeiro, with annual production capacity of 1.4 million barrels of lubricants per year, including 48,000 barrels of grease per year.

Sugar Logistics

The Company owns and operates a sugar-loading terminal at the Port of Santos in the State of Sao Paulo through its subsidiary Rumo Logistica. It offers logistics solution to sugar producers located in the Center South of Brazil by transporting sugar from the mill by truck or rail to be loaded at its bulk sugar port terminal in Santos. It also offer sugar storage services.

The Company competes with Copersucar, Sudzucker AG, Petrobras, Ultrapar S.A., Shell Brasil Ltda. and AleSat Combustiveis S.A.

Advisors' Opinion:

• [By Maxx Chatsko]

  Partnership outlook
  I am still hoping that Codexis will be tapped by Raizen, a joint venture between Shell and sugar giant Cosan (NYSE: CZZ  ) , as its exclusive cellulase enzyme provider. Raizen has not been shy about its cellulosic ethanol ambitions -- planning a 10 million gallon per year facility -- but has yet to choose an enzyme technology. Investors should be careful not to assume that Codexis is a lock for the partnership (Raizen is the largest investor in Codexis), but with more than 580 million gallons of first-generation ethanol capacity the opportunity is enormous.

• [By Monica Gerson]

  Cosan (NYSE: CZZ) is estimated to post its Q1 earnings at $0.16 per share.

  ViaSat (NASDAQ: VSAT) is projected to post its Q4 earnings at $0.11 per share on revenue of $348.98 million.

• [By Dan Caplinger]

  ADM's renewable-fuel business grabs most of the attention from investors. The drought has also had a big impact in this segment as well, as ADM has had to idle ethanol production facilities because of low corn supplies following the drought. Moreover, with sugar-based ethanol competitors Bunge (NYSE: BG  ) and Cosan (NYSE: CZZ  ) already benefiting from pricing disparities between sugar and corn, prospects of potential tariffs on U.S. ethanol in Europe could give Brazilian sugar-based ethanol a competitive advantage, further hurting ADM.

Top Net Payout Yield Stocks To Invest In 2015: Physicians Realty Trust (DOC)

Physicians Realty Trust, incorporated on April 9, 2013, is a real estate investment trust (REIT). The Company is a self-managed healthcare real estate company. The Company is engaged in acquiring, developing, owning and managing healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. The Company invests in real estate that is integral to providing healthcare services. The Company�� properties are located on a campus with a hospital or other healthcare facilities or strategically located and affiliated with a hospital or other healthcare facilities. The Company�� principal investments will include medical office buildings, outpatient treatment facilities, acute and post-acute care hospitals, as well as other real estate integral to healthcare providers. The Company�� initial portfolio will consist of 19 medical office buildings located in 10 states with approximately 528,048 net leasable square feet. Effective August 27, 2013, Physicians Realty Trust acquired an undisclosed hospital, located in Plano, Texas, an owner and operator of hospital. In September 2013, Physicians Realty Trust completion of the sale-leaseback of the surgical hospital and adjacent medical office building occupied by the Foundation Surgical Hospital of El Paso, L.L.C. In October 2013, Physicians Realty Trust announced the completion of the acquisition of the Foundation Outpatient Care Building located in Oklahoma City, OK. Effective January 8, 2014, Physicians Realty Trust acquired an undisclosed ambulatory surgery center, located in Great Falls, Montana. In February 2014, the Company's operating partnership, Physicians Realty L.P., closed on the purchase and leaseback of four medical office buildings to an Atlanta, Georgia-based family medical practice.

The Company�� Surgical Hospital-New Orleans, Louisiana property is a 57,000 square foot, 42-bed acute care surgical hospital with six operating rooms. The hospital specializes in ortho/neuro spine surgery, orthopedics, ! weight loss surgery and other scheduled general surgery procedures. Surgical Hospital and Medical Office Building-El Paso, Texas property is a 77,000 square foot, 40-bed acute care hospital with six operating rooms. The Company's initial portfolio was acquired or developed by healthcare real estate funds managed by B.C. Ziegler & Company (Ziegler), a specialty investment banking firm focused on the healthcare industry, and another subsidiary of The Ziegler Companies, Inc. As part of its formation transactions, the Ziegler Funds will contribute their ownership interests in these properties to its operating partnership.

Advisors' Opinion:

• [By Marc Bastow]

  Healthcare REIT Physicians Realty Trust (DOC) was right up their with Ford in raising its quarterly dividend 25%, to 22.5 cents per share, payable Feb. 7 to shareholders of record as of Jan. 24.
  DOC Stock Dividend Yield: 7.02%

Top Net Payout Yield Stocks To Invest In 2015: Polydex Pharmaceuticals Ltd (POLXF.PK)

Polydex Pharmaceuticals Limited, incorporated on June 14, 1979, is engaged in the research, development, manufacture and marketing of biotechnology-based products for the human pharmaceutical market. The Company also manufactures bulk pharmaceutical intermediates for the global veterinary pharmaceutical industry. It focuses on the manufacture and sale of Dextran and derivative products, including Iron Dextran and Dextran Sulphate, and other specialty chemicals. Dextran, a generic name applied to certain synthetic compounds formed by bacterial growth on sucrose, is a polymer or giant molecule. The products of the Company include Iron Dextran and Dextran Sulphate. The wholly owned subsidiaries of the Company include Dextran Products Limited (Dextran Products) and Chemdex Inc (Chemdex).

Iron Dextran

Iron Dextran is a derivative of Dextran produced by complexing iron with Dextran. Iron Dextran is injected into pigs at birth as a treatment for anemia. The Company sells Iron Dextran to independent distributors and wholesalers in Europe, the Far East and Canada. Chemdex, Inc. has United States FDA approval for the manufacture and sale of Iron Dextran for veterinary use.

Dextran Sulphate

Dextran Sulphate is a specialty chemical derivative of Dextran used in research applications by the pharmaceutical industry and other centers of chemical research. Dextran Sulphate manufactured by the Company is sold primarily to independent distributors and wholesalers in the United States and Europe as analytical chemical applications.

Advisors' Opinion:

• [By The GeoTeam]

  Polydex Pharmaceuticals (POLXF.PK) Limited, through its subsidiaries, engages in the development, manufacture, and marketing of biotechnology-based products for the human pharmaceutical market. It is also involved with manufacture of bulk pharmaceutical intermediates for the veterinary pharmaceutical industry worldwide. It primarily offers Dextran and Dextran derivative products.